Indian imports threatened by regulatory body problems
This article was originally published in Clinica
Executive Summary
There are concerns that a shortage of staff and expertise at India's medtech and pharma regulatory body, the Central Drugs Standard Control Organisation (CDSCO), will lead to a blocking of imports.